Organizations Filed Purposes:
THE VISION OF ARKANSAS CHILDREN'S RESEARCH INSTITUTE IS TO BE A LEADER IN CUTTING-EDGE RESEARCH THAT IMPROVES THE HEALTH AND WELL-BEING OF CHILDREN AND THEIR FAMILIES. IN SUPPORT OF THIS VISION, ARKANSAS CHILDREN'S RESEARCH INSTITUTE AIMS TO (1) RECRUIT AND RETAIN HIGHLY QUALIFIED SCIENTISTS; (2) PROVIDE AN EXCEPTIONAL ENVIRONMENT FOR RESEARCH; (3) SEEK AND OBTAIN APPROPRIATE FUNDING FOR RESEARCH; (4) MANAGE AND LEVERAGE RESOURCES TO SUCCEED IN ITS MISSION; (5) SUPPORT TRANSFER OF DISCOVERIES TO INDUSTRY TO CREATE JOBS IN ARKANSAS; (6) FORM PRODUCTIVE COLLABORATIONS WITH OTHER INSTITUTIONS, ESPECIALLY THOSE IN ARKANSAS; (7) PROMOTE A STRONG RESEARCH CAPABILITY TO SUPPORT RECRUITMENT OF THE BEST POSSIBLE PHYSICIANS FOR THE CAMPUS; AND (8) SERVE AS A KEY LEARNING LABORATORY FOR VARIOUS TRAINEES TO LEARN THE DISCIPLINES AND METHODOLOGIES OF RESEARCH.
TO IMPROVE CHILDREN'S HEALTH, DEVELOPMENT AND WELL-BEING THROUGH HIGH QUALITY RESEARCH.
DURING FY20, ARKANSAS CHILDREN'S RESEARCH INSTITUTE (ACRI) RECEIVED NEW AWARDS FROM THE NATIONAL INSTITUTE OF HEALTH (NIH) INCLUDING $2.1 MILLION TO CONTINUE AS A MEMBER OF A PEDIATRIC CLINICAL TRIAL NETWORK THAT PROVIDES CHILDREN IN MEDICALLY UNDERSERVED OR RURAL AREAS ACCESS TO CLINICAL STUDIES ON ENVIRONMENTAL INFLUENCES ON EARLY DEVELOPMENT AND $446,000 TO EXAMINE EFFECTS OF VIRAL RESPIRATORY INFECTIONS ON ASTHMA. ACRI WAS ALSO ABLE TO RECRUIT 3 NEW RESEARCH SCIENTISTS DURING THE FISCAL YEAR, ONE OF WHICH WILL LEAD THE ORGANIZATION AS ACRI PRESIDENT. ACRI PROVIDED THE RESEARCH INFRASTRUCTURE TO OVER 120 RESEARCHERS WHO PUBLISHED THEIR SCIENTIFIC FINDINGS IN 257 PEER-REVIEWED SCIENTIFIC JOURNAL ARTICLES, OF WHICH 37.7% OF THE PUBLICATIONS APPEARED IN THE TOP 10% RANKING JOURNALS.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Barry Brady | VICE PRESIDENT & COO | 45 | $238,295 |
| Jill Hernandez | RESEARCH PHARMACY COORDINATOR | 43 | $123,246 |
| Rick Barr Md | INTERIM PRESIDENT | 11.16 | $117,775 |
| Thomas Blake Harrison | ANIMAL RESEARCH DIRECTOR | 42 | $115,062 |
| Phaedra Yount | RESEARCH GRANTS & CONTRACTS ADMIN. DIRECTOR | 40 | $111,511 |
| Stewart Macleod | DEVELOPMENT GENOMICS DIRECTOR | 40 | $105,738 |
| Janet Storment | CLINICAL TRIALS ADMINISTRATOR | 40 | $105,549 |
| Stacie Jones Md | BOARD VICE CHAIR/DIRECTOR | 7.13 | $65,575 |
| Mary Aitken Md | INTERIM PRESIDENT (PARTIAL YEAR) | 11.07 | $26,432 |
| Marshall Summar Md | TRUSTEE/DIRECTOR | 0.02 | $0 |
| Daniel Sui Md | TRUSTEE/DIRECTOR | 0.02 | $0 |
| Jeffery Nolan | BOARD TREASURER/DIRECTOR | 0.18 | $0 |
| Pope Moseley Md | TRUSTEE/DIRECTOR | 0 | $0 |
| Mark Millsap | TRUSTEE/DIRECTOR | 0.05 | $0 |
| Don Gibson | TRUSTEE/DIRECTOR | 0.11 | $0 |
| Dee Ann English | BOARD CHAIR/DIRECTOR | 0.23 | $0 |
| Joycelyn Elders Md | TRUSTEE/DIRECTOR | 0.08 | $0 |
| Larry Cornett | TRUSTEE/DIRECTOR | 0.1 | $0 |
| Dan Acosta Phd | TRUSTEE/DIRECTOR | 0 | $0 |
| Greg Kearns | FORMER PRESIDENT | 0 | $0 |
| Marcella Doderer | CEO/AR CHILDREN'S | 0.16 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202101339349301890_public.xml